麦田稻草人
Lv71
4975 积分
2021-05-28 加入
-
Patient-reported Outcomes Utilizing the BREAST-Q Questionnaire After Breast-Conserving Surgery With and Without Oncoplastic Breast Surgery: A Systematic Review and Meta-analysis
5小时前
已完结
-
Oncologic and cosmetic outcomes of oncoplastic breast-conserving surgery after neoadjuvant systemic therapy: systematic review and meta-analysis
5小时前
已完结
-
Establishment of RWS guidance reflecting contributions of China to regulatory science
5天前
已完结
-
Neoadjuvant target therapy with ensartinib in lung adenocarcinoma with EML4-ALK fusion variant: a case report and literature review
6天前
已完结
-
Overall Survival with Neoadjuvant Nivolumab plus Chemotherapy in Lung Cancer
16天前
已完结
-
Neoadjuvant and Adjuvant Treatments for Early Stage Resectable NSCLC: Consensus Recommendations From the International Association for the Study of Lung Cancer
17天前
已完结
-
Zolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, untreated, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma (SPOTLIGHT): a multicentre, randomised, double-blind, phase 3 trial
1个月前
已完结
-
The current status of the biosimilars landscape in China
1个月前
已完结
-
Alpelisib plus fulvestrant in PIK3CA-mutated, hormone receptor-positive advanced breast cancer after a CDK4/6 inhibitor (BYLieve): one cohort of a phase 2, multicentre, open-label, non-comparative study
2个月前
已完结
-
Advances in Ovarian Cancer Care and Unmet Treatment Needs for Patients With Platinum Resistance
2个月前
已完结